antiprolif
effect
bestatin
actinonin
cell
compar
inhibitori
activ
cell
surfac
aminopeptidas
result
strongli
suggest
inhibit
cell
surfac
aminopeptidas
main
reason
inhibit
cell
prolifer
confirm
studi
effect
buthionin
sulfoximin
propano
acid
verapamil
inhibit
cell
prolifer
bestatin
actinonin
bso
inhibit
efflux
drug
mediat
multidrug
resistanceassoci
protein
mrp
increas
action
inhibitor
indic
latter
enter
cell
export
mediat
mrp
cell
line
verapamil
significantli
increas
inhibitori
activ
bestatin
cell
indic
intracellular
concentr
bestatin
mediat
also
pglycoprotein
q
bestatin
dipeptid
synthes
streptomyc
olivoreti
divers
antitumor
immunomodulatori
activ
use
clinic
trial
treatment
leukemia
propos
use
immunolog
adjuv
dna
vaccin
mechan
action
bestatin
known
muller
cowork
first
prove
bind
cell
surfac
protein
suggest
biolog
activ
consequ
inhibit
cell
surfac
leucin
aminopeptidas
aminopeptidas
w
aminopeptidas
n
apn
propos
key
aminopeptidas
respons
biolog
effect
aminopeptidas
inhibitor
addit
support
idea
apn
involv
regul
cell
prolifer
provid
fact
increas
express
apn
associ
increas
prolifer
activ
cell
cord
blood
cell
apn
antisens
rna
inhibit
cell
prolifer
cell
hand
sensit
differ
cell
line
bestatin
correl
express
apn
furthermor
amastatin
inhibitor
apn
antibodi
apn
inhibit
enzym
activ
inhibit
cell
prolifer
antiapn
antibodi
also
hinder
inhibitori
effect
anoth
inhibitor
apn
actinonin
cell
prolifer
find
support
fact
bestatin
methyl
ester
hydrophob
deriv
bestatin
induc
apoptosi
lower
concentr
bestatin
suggest
aminopeptidas
inhibitor
inhibit
cell
prolifer
intracellular
activ
studi
sought
elucid
role
inhibit
cell
surfac
aminopeptidas
antiprolif
activ
bestatin
quantit
comparison
two
activ
cell
comparison
use
actinonin
anoth
inhibitor
aminopeptidas
n
also
shown
inhibit
cell
prolifer
sinc
found
aminopeptidas
inhibitor
could
inhibit
cell
prolifer
sole
inhibit
cell
surfac
aminopeptidas
test
hypothesi
actinonin
bestatin
act
intracellularli
measur
antiprolif
effect
inhibitor
two
leukemia
cell
line
presenc
drug
efflux
modifi
cell
shown
express
multidrug
resistanceassoci
protein
mrp
pglycoprotein
pgp
belong
group
transport
protein
known
decreas
intracellular
drug
accumul
caus
drug
resist
cancer
cell
review
ref
drug
efflux
modifi
use
buthionin
sulfoximin
bso
inhibitor
glutathion
synthesi
impair
action
mrp
glutathionedepend
drug
efflux
pump
ethenyl
phenyl
thio
methyl
thio
propano
acid
leukotrien
receptor
antagonist
also
inhibit
mrpdepend
transport
verapamil
calcium
channel
blocker
impair
activ
pgp
bestatin
actinonin
inhibit
cell
prolifer
intracellular
activ
inhibitor
efflux
would
expect
increas
effect
cell
bestatin
actinonin
verapamil
bso
purchas
sigma
chemic
co
usa
substrat
alamca
leumca
argmca
bachem
switzerland
biomol
research
laboratori
usa
human
histiocyt
lymphoma
cell
line
human
myelogen
leukemia
cell
line
obtain
atcc
rockvil
md
usa
cell
cultur
rpmi
medium
flow
laboratori
inc
supplement
fetal
bovin
serum
south
hyclon
road
logan
ut
usa
mm
glutamin
gibco
ltd
uk
incub
humidifi
co
atmospher
cell
suspend
final
concentr
cellsml
rpmi
medium
supplement
fetal
bovin
serum
mm
glutamin
seed
cultur
plate
variou
concentr
aminopeptidas
inhibitor
ad
well
plate
incub
day
humidifi
co
atmospher
cell
count
day
hemocytomet
cell
viabil
estim
stain
cell
trypan
blue
solut
concentr
inhibitor
cultur
media
monitor
measur
inhibitori
activ
medium
aminopeptidas
n
inhibitori
activ
remain
constant
throughout
experi
concentr
inhibitor
caus
inhibit
cell
prolifer
ic
determin
plot
inhibit
cell
prolifer
inhibitor
concentr
effect
bso
antiprolif
activ
bestatin
actinonin
test
preincub
cell
presenc
mm
bso
h
ad
inhibitor
verapamil
ad
cell
suspens
time
aminopeptidas
inhibitor
final
concentr
inhibitor
cell
cultur
mm
bestatin
mm
actinonin
experi
cell
mm
bestatin
mm
actinonin
experi
cell
cell
count
third
fourth
fifth
day
addit
aminopeptidas
inhibitor
cell
rins
twice
ice
cold
phosphatebuff
salin
pb
suspend
pb
ca
mg
ion
cell
suspens
preincub
without
inhibitor
h
room
temperatur
addit
substrat
final
concentr
incub
min
reaction
stop
centrifug
g
min
concentr
releas
product
measur
supernat
nm
fluoresc
spectromet
concentr
inhibitor
caus
inhibit
aminopeptidas
activ
ic
determin
plot
enzym
activ
concentr
inhibitor
aminopeptidas
activ
cultur
media
determin
ml
media
obtain
centrifug
cell
cultur
densiti
cellsml
ic
inhibit
prolifer
bestatin
actinonin
ic
ic
valu
bestatin
cell
report
literatur
mm
mm
mm
larg
differ
determin
ic
valu
bestatin
actinonin
experiment
system
ic
valu
determin
day
experi
list
tabl
ic
actinonin
similar
valu
determin
leukemia
cell
line
ic
bestatin
cell
within
rang
valu
obtain
previous
bestatin
cell
ten
time
higher
valu
report
sekin
cowork
sinc
bestatin
competit
inhibitor
apn
leucin
aminopeptidas
aminopeptidas
b
sinc
actinonin
competit
inhibit
apn
assay
cell
surfac
aminopeptidas
activ
substrat
enzym
cell
show
stronger
activ
alamca
cell
activ
argmca
leumca
tabl
result
agre
find
bauvoi
cowork
show
cell
exhibit
highest
activ
substrat
hydrophob
amino
acid
residu
yamada
cowork
show
cell
express
high
level
aminopeptidas
b
cell
line
also
shown
express
apn
ic
valu
tabl
micromolar
rang
compar
k
constant
bestatin
apn
aminopeptidas
b
leucin
aminopeptidas
respect
k
inhibit
apn
actinonin
bestatin
actinonin
inhibit
cell
prolifer
inhibit
cell
surfac
aminopeptidas
ic
valu
would
similar
correspond
ic
ic
valu
seen
much
higher
corr
lation
exist
ic
ic
valu
two
inhibitor
two
cell
line
tabl
reason
high
ic
ic
ratio
could
high
concentr
solubl
aminopeptidas
cell
cultur
medium
result
shown
tabl
indic
activ
alamca
leumca
cultur
medium
origin
fetal
bovin
serum
activ
argmca
releas
cell
total
solubl
aminopeptidas
activ
repres
total
extracellular
aminopeptidas
activ
cell
cultur
begin
experi
day
high
enough
account
high
ic
valu
besid
accord
equat
ic
would
depend
enzym
concentr
case
latter
region
k
case
mm
rang
expect
cell
cultur
result
tabl
show
bso
inhibit
mrpmediat
efflux
drug
increas
antiprolif
effect
aminopeptidas
inhibitor
cell
line
indic
bestatin
actinonin
must
enter
cell
interact
insid
cell
involv
inhibit
cell
prolifer
zaman
cowork
observ
decreas
ic
valu
anthracyclin
vincristin
presenc
mm
bso
mean
higher
inhibi
tion
cell
prolifer
valu
obtain
concentr
correspond
ic
result
tabl
confirm
effect
lead
conclus
antiprolif
effect
bestatin
actinonin
result
intracellular
action
inhibitor
mrp
mm
concentr
increas
antiprolif
effect
aminopeptidas
inhibitor
cell
bestatin
cell
mm
concentr
also
increas
significantli
effect
actinonin
cell
tabl
result
confirm
conclus
bestatin
actinonin
enter
cell
intracellular
concentr
modifi
mrpmediat
drug
efflux
verapamil
inhibitor
drug
efflux
mediat
pgp
exhibit
antiprolif
effect
cell
mm
concentr
preclud
use
studi
effect
action
bestatin
actinonin
cell
howev
show
signific
effect
action
bestatin
cell
tabl
furthermor
ic
valu
bestatin
cell
increas
significantli
time
incub
cell
presenc
bestatin
fig
explain
induct
pgp
effect
shown
differ
anticanc
drug
cell
chaudhari
roninson
result
suggest
intracellular
concentr
bestatin
mediat
pgp
verapamil
hand
show
effect
action
actinonin
tabl
suggest
actinonin
good
ligand
pgpmediat
efflux
conclus
aminopeptidas
inhibitor
bestatin
actinonin
act
intracellularli
aris
question
enter
cell
possibl
explan
could
passiv
transport
lipid
bilay
receptormedi
endocytosi
transport
mediat
special
protein
express
cell
surfac
passiv
transport
impli
result
sekin
et
al
show
hydrophob
deriv
bestatin
induc
apoptosi
lower
concentr
bestatin
also
long
incub
time
necessari
detect
antiprolif
effect
aminopeptidas
inhibitor
receptormedi
endocytosi
indic
ic
valu
tabl
lower
aminopeptidas
inhibitor
cell
exhibit
higher
express
apn
suggest
endocytosi
bestatin
actinonin
could
mediat
apn
alreadi
shown
apn
serv
receptor
coronaviru
tgev
final
bestatin
actinonin
could
enter
cell
also
special
transport
protein
shown
hela
cell
transfect
synergi
inhibitor
drug
efflux
bestatin
constitut
first
report
leukemia
cell
develop
resist
bestatin
find
biolog
effect
bestatin
actinonin
result
intrarath
extracellular
activ
point
need
search
intracellular
target
possibl
design
better
ther
apeut
agent
anoth
import
conclus
studi
bestatin
actinonin
suitabl
investig
biolog
role
cell
surfac
aminopeptidas
